JP Morgan Chase
LGND icon

JP Morgan Chase’s Ligand Pharmaceuticals LGND Stock Holding History

JP Morgan Chase’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-57,868
Closed -$2.63M – 5551
2020
Q1 		$2.63M Sell
57,868
-496,129
-90% -$28.1M ﹤0.01% 2763
2019
Q4 		$36M Hold
553,997
– – 0.01% 1157
2019
Q3 		$34.4M Buy
+553,997
New +$34.8M 0.01% 1177
2019
Q2 		– Sell
-103,714
Closed -$8.13M – 5892
2019
Q1 		$8.13M Sell
103,714
-306,013
-75% -$23.2M ﹤0.01% 2228
2018
Q4 		$34.7M Buy
+409,727
New +$43.7M 0.01% 1095
2017
Q1 		– Sell
-24,045
Closed -$1.52M – 5152
2016
Q4 		$1.52M Buy
+24,045
New +$1.52M ﹤0.01% 3237

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's LGND Position: Q2 2026 in Review

JP Morgan Chase reduced its Ligand Pharmaceuticals (LGND) stake by 15% in Q2 2026, selling an estimated $3.12M and leaving 73,052 shares worth $23.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

JP Morgan Chase first reported a position in LGND in Q2 2013 and has held it in 46 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • JP Morgan Chase held 73,052 shares of Ligand Pharmaceuticals worth $23.2M as of Q2 2026.
  • JP Morgan Chase sold 13,222 Ligand Pharmaceuticals shares in Q2 2026, an estimated $3.12M.
  • Ligand Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2097 holding.
  • JP Morgan Chase first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 46 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.